Skip to main content
Published locations for FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
User login
Username
Password
Reset your password
/content/fda-alert-confirms-heart-and-cancer-risks-tofacitinib-xeljanz-0
/gihepnews/article/235670/ibd-intestinal-disorders/fda-alert-confirms-heart-and-cancer-risks